Cost-effectiveness of rotavirus vaccination programs in Taiwan

Vaccine

Volumn 31, Issue 46, 2013, Pages 5458-5465

  Chang, Wan Chi ^a   Yen, Catherine ^b   Chi, Cheng Liang ^a   Wu, Fang Tzy ^c   Huang, Yhu Chering ^d   Lin, Jen Shiou ^e   Huang, Fu Chen ^d   Tate, Jacqueline E ^b   Wu, Ho Sheng ^c,f   Hsiung, Chao A ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Centers for Disease Control   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cost effectiveness; Gastroenteritis; Rotavirus; Rotavirus vaccine

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILDHOOD MORTALITY; COST EFFECTIVENESS ANALYSIS; DIARRHEA; GASTROENTERITIS; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITALIZATION COST; HUMAN; OUTCOME ASSESSMENT; OUTPATIENT CARE; PRIORITY JOURNAL; ROTAVIRUS INFECTION; SENSITIVITY ANALYSIS; TAIWAN; VACCINATION;

COST-EFFECTIVENESS; GASTROENTERITIS; ROTAVIRUS; ROTAVIRUS VACCINE;

CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; FEMALE; GASTROENTERITIS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MODELS, STATISTICAL; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TAIWAN; VACCINATION;

EID: 84886094845     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.103     Document Type: Article

References (32)

1. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., et al. Global mortality associated with rotavirus disease among children in 2004. Journal of Infectious Diseases 2009, 200(November (Suppl. 1)):S9-S15.
2. Parashar U.D., Gibson C.J., Bresse J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerging Infectious Diseases 2006, 12(February (2)):304-306.
3. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D., et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infectious Diseases 2012, 12(February (2)):136-141.
4. Chen K.T., Chen P.Y., Tang R.B., Huang Y.F., Lee P.I., Yang J.Y., et al. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. Journal of Infectious Diseases 2005, 192(September (Suppl. 1)):S44-S48.
5. Chen S.Y., Chang Y.C., Lee Y.S., Chao H.C., Tsao K.C., Lin T.Y., et al. Molecular epidemiology and clinical manifestations of viral gastroenteritis in hospitalized pediatric patients in Northern Taiwan. Journal of Clinical Microbiology 2007, 45(June (6)):2054-2057.
6. Lu C.Y., Lauderdale T.L., Fang Y.H., Wang C.Y., Ho Y.H., Hung C.L., et al. Disease burden and related medical costs of rotavirus infections in Taiwan. BMC Infectious Diseases 2006, 6:176.
7. Wu F.T., Liang S.Y., Tsao K.C., Huang C.G., Lin C.Y., Lin J.S., et al. Hospital-based surveillance and molecular epidemiology of rotavirus infection in Taiwan, 2005-2007. Vaccine 2009, 27(November (Suppl. 5)):F50-F54.
8. Rotavirus vaccines: an update Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations 2009, 84(December (50)):533-540.
9. Esposito D.H., Tate J.E., Kang G., Parashar U.D. Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2011, 52(January (2)):171-177.
10. Rheingans R.D., Antil L., Dreibelbis R., Podewils L.J., Bresee J.S., Parashar U.D. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. Journal of Infectious Diseases 2009, 200(November (Suppl. 1)):S16-S27.
11. Tate J.E., Rheingans R.D., O'Reilly C.E., Obonyo B., Burton D.C., Tornheim J.A., et al. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in Kenya. Journal of Infectious Diseases 2009, 200(November (Suppl. 1)):S76-S84.
12. Organization W.H. Generalized cost-effectiveness analysis: a guide 2002, World Health Organization, Geneva.
13. Phua K.B., Lim F.S., Lau Y.L., Nelson E.A., Huang L.M., Quak S.H., et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine 2009, 27(October (43)):5936-5941.
14. Vesikari T., Matson D.O., Dennehy P., Itzler R.F., Boslego J.W., Heaton P.M., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New England Journal of Medicine 2006, 354(January (1)):23-33.
15. Glass R.I., Kilgore P.E., Holman R.C., Jin S., Smith J.C., Woods P.A., et al. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. Journal of Infectious Diseases 1996, 174(September (Suppl. 1)):S5-S11.
16. Parashar U.D., Holman R.C., Clarke M.J., Bresee J.S., Glass R.I. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. Journal of Infectious Diseases 1998, 177(January (1)):13-17.
17. Chen K.T., Fan S.F., Tang R.B., Huang Y.F., Lee P.I., Chen P.Y., et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan. Vaccine 2007, 25(May (21)):4266-4272.
18. Itzler R.F., Chen P.Y., Lac C., El Khoury A.C., Cook J.R. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children<=5 years of age in Taiwan. Journal of Medical Economics 2011, 14(6):748-758.
19. Mast T.C., Chen P.Y., Lu K.C., Hsu C.M., Lin H.C., Liao W.C., et al. Epidemiology and economic burden of rotavirus gastroenteritis in hospitals and paediatric clinics in Taiwan, 2005-2006. Vaccine 2010, 28(April (17)):3008-3013.
20. Wu C.L., Yang Y.C., Huang L.M., Chen K.T. Cost-effectiveness of childhood rotavirus vaccination in Taiwan. Vaccine 2009, 27(March (10)):1492-1499.
21. Cortese M.M., Tate J.E., Simonsen L., Edelman L., Parashar U.D. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatric Infectious Disease Journal 2010, 29(June (6)):489-494.
22. Curns A.T., Steiner C.A., Barrett M., Hunter K., Wilson E., Parashar U.D. Reduction in acute gastroenteritis hospitalizations in US children after introduction of rotavirus vaccine - analysis of hospital discharge data from 18 states. Journal of Infectious Diseases 2010, 201(June (11)):1617-1624.
23. Field E.J., Vally H., Grimwood K., Lambert S.B. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010, 126(September (3)):e506-e512.
24. Lopman B.A., Curns A.T., Yen C., Parashar U.D. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. Journal of Infectious Diseases 2011, 204(October (7)):980-986.
25. Paulke-Korinek M., Kundi M., Rendi-Wagner P., de Martin A., Eder G., Schmidle-Loss B., et al. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011, 29(March (15)):2791-2796.
26. Yen C., Armero Guardado J.A., Alberto P., Rodriguez Araujo D.S., Mena C., Cuellar E., et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatric Infectious Disease Journal 2011, 30:S6-S10.
27. Yen C., Tate J.E., Wenk J.D., Harris J.M., Parashar U. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. Pediatrics 2011, 127(1).
28. Braeckman T., Van Herck K., Meyer N., Pirçon J.Y., Soriano-Gabarró M., Heylen E., et al. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. BMJ 2012, 345:e4752.
29. Cortese M.M., Leblanc J., White K.E., Jerris R.C., Stinchfield P., Preston K.L., et al. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics 2011, 128(December (6)):e1474-e1481.
30. Martinon-Torres F., Bouzon Alejandro M., Redondo Collazo L., Sánchez Lastres J.M., Pértega Díaz S., Seoane Pillado M.T., et al. Effectiveness of rotavirus vaccination in Spain. Human Vaccines 2011, 7(July (7)):757-761.
31. Staat M.A., Payne D.C., Donauer S., Weinberg G.A., Edwards K.M., Szilagyi P.G., et al. Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics 2011, 128(August (2)):e267-e275.
32. De la Hoz-Restrepo F., Castañeda-Orjuela C., Paternina A., Alvis-Guzman N. Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines. Vaccine 2013, 31S(July (3)):C80-C87.